Cargando…
Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost
Myocardial protection against ischemia/reperfusion injury (IRI) is mediated by various ligands, activating different cellular signaling cascades. These include classical cytosolic mediators such as cyclic-GMP (c-GMP), various kinases such as Phosphatydilinositol-3- (PI3K), Protein Kinase B (Akt), Mi...
Autores principales: | Efentakis, Panagiotis, Andreadou, Ioanna, Iliodromitis, Konstantinos E., Triposkiadis, Filippos, Ferdinandy, Péter, Schulz, Rainer, Iliodromitis, Efstathios K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696420/ https://www.ncbi.nlm.nih.gov/pubmed/36430599 http://dx.doi.org/10.3390/ijms232214121 |
Ejemplares similares
-
Reciprocal regulation of eNOS, H(2)S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin
por: Sigala, Fragiska, et al.
Publicado: (2017) -
Type 2 Diabetes Mellitus Treatment and Beyond: A Glance in Our Armamentarium
por: Iliodromitis, Konstantinos, et al.
Publicado: (2023) -
Ischemic preconditioning: Protection against myocardial necrosis and apoptosis
por: Iliodromitis, Efstathios K, et al.
Publicado: (2007) -
ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
por: Triposkiadis, Filippos, et al.
Publicado: (2021) -
Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
por: Andreadou, Ioanna, et al.
Publicado: (2017)